Carcinogenic effects of cadmium in the noble (NBL/Cr) rat: Induction of pituitary, testicular, and injection site tumors and intraepithelial proliferative lesions of the dorsolateral prostate

Toxicological Sciences

Volumn 52, Issue 2, 1999, Pages 154-161

  Waalkes, Michael P ^a   Anver, Miriam ^b   Diwan, Bhalchandra A ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Cadmium; Carcinogenesis; Proliferative lesions; Prostate; Rat

Indexed keywords

CADMIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL HYPERPLASIA; CONTROLLED STUDY; DOSE RESPONSE; HYPOPHYSIS ADENOMA; LUNG CANCER; NONHUMAN; PROSTATE; RAT; TESTIS FUNCTION;

EID: 0033375226     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/52.2.154     Document Type: Article

References (42)

1. Bosland, M. C. (1994). Male reproductive system. In Target Organ Toxicology: Carcinogenesis (M. P. Waalkes and J. M. Ward, Eds.), pp. 339-401. Raven Press, New York.
2. Bosland, M. C. (1996). Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. Prog. Clin. Biol. Res. 394, 309-352.
3. Coffey D. S., and Isaacs, J. T. (1981) Control of prostate growth. Urology 17(suppl. 3), 17-24.
4. Coogan, T. P., Shiraishi, N., and Waalkes, M. P. (1994). Apparent quiescence of the metallothionein gene in the rat ventral prostate: Association with cadmium-induced prostate tumors in rats. Environ. Health Perspect. 102, 137-139.
5. Coogan, T. P., Shiraishi, N., and Waalkes, M. P. (1995). Minimal basal activity and lack of metal-induced activation of the metallothionein gene correlates with lobe-specific sensitivity to the carcinogenic effects of cadmium in the rat prostate. Toxicol. Appl. Pharmacol. 132, 164-173.
6. Coogan, T. P., Shiraishi, N., and Waalkes, M. P. (1997). Metallothionein gene expression in the reproductive tissues of the male Wistar rat: Effects of treatment with metals or glueocorticoids. Toxic Subst. Mech. 16, 357-370.
7. Elghany, N. A., Schumacher, M. C., Slattery, M. L., West, D. W., and Lee, J. S. (1990) Occupation, cadmium exposure, and prostate cancer. Epidemiology 1, 107-115.
8. Elinder, C.-G. (1985). Normal values for cadmium in human tissue, blood, and urine in different countries. In Cadmium and Health: A Toxicological and Epidemiological Appraisal, Vol. 1 (L. Friberg, C.-G. Elinder, T. Kjellström, and G. F. Nordberg, Eds.) pp. 81-102. CRC Press, Boca Raton, FL.
9. Fort, F. L., Miyajima, H., Suzuki, T., Yamamoto, M., Hamashima, T., Sato, S., Kitazaki, T., Mahony, M. C., and Hogden, G. D. (1995). Mechanism for species-specific induction of Leydig cell tumors in rats by lansoprazole. Fundam. Appl. Toxicol. 26, 191-202.
10. Garcia Sanchez, A., Antona, J. F., and Urrutia, M. (1992). Geochemical prospection of cadmium in a high-incidence area of prostate cancer, Serra de Gata, Salamanca, Spain. Sci. Total Environ. 116, 243-251.
11. Ghatak, S., Oliveria, P., Kaplan, P., and Ho, S. M. (1996). Expression and regulation of metallothionein mRNA levels in the prostates of Noble rats: Lack of expression in the ventral prostate and regulation by sex hormones in the dorsolateral prostate. Prostate 29, 91-100.
12. Goering, P. L., Waalkes, M. P., and Klaassen, C. D. (1994). Toxicology of cadmium. In Handbook of Experimental Pharmacology; Toxicology of Metals, Biochemical Effects, Vol. 115 (R. A. Goyer and M. G. Cherian. Eds.), pp. 189-214. Springer-Verlag, New York.
13. Gunn, S. A., and Gould, T. C. (1970). Cadmium and other mineral elements. In The Testis, Volume III, Influencing Factors (A. D. Johnson, W. R. Gomes, and N. L. Van Demark, Eds.), pp. 377-481. Academic Press, New York.
14. IARC (1993). International Agency for Research on Cancer Monographs, Volume 58. Beryllium, Cadmium, Mercury, and Exposures in the Glass Manufacturing Industry, pp. 119-238. IARC Press, Lyon, France.
15. Kasprzak, K. S., and Poirier, L. A. (1985). Effects of calcium and magnesium actetates on tissue distribution of carcinogenic doses of cadmium chloride in Wistar rats. Toxicology 34, 221-230.
16. Key, T. (1995). Risk factors for prostate cancer. Cancer Surv. 23, 63-77.
17. Kolonel, L. N. (1996). Nutrition and prostate cancer. Cancer Causes Control 7, 83-94.
18. Mettlin, C. (1997). Recent developments in the epidemiology of prostate cancer. Eur. J. Cancer 33, 340-347.
19. Misra, R. R., Crance, K. A., Bare, R. M., and Waalkes, M. P. (1997). Lack of correlation between the inducibility of metallothionein mRNA and metallothionein protein in cadmium-exposed rodents. Toxicology 117, 99-109.
20. Murakami, M., Hosokawa, S., Yamada, T., Harakawa, M., Ito, M., Koyama, Y., Kimura, J., Yoshitake, A., and Yamada, H. (1995). Species-specific mechanism in rat Leydig cell tumorigenesis by procymidone. Toxicol. Appl. Pharmacol. 131, 244-252.
21. Nobel, R. L. (1977). The development of prostatic adenocarcinomas in Nb rats following prolonged sex hormone administration. Cancer Res. 37, 1929-1933.
22. Noble, R. L. (1982). Prostate carcinoma of the Nb rat in relation to hormones. Int. Rev. Exp. Pathol. 23, 113-159.
23. Nyska, A., Leininger, J. R., Maronpol, R. R., Haseman, J. K., and Hailey, J. R. (1998). Effect of individual versus group caging on the incidence of pituitary and Leydig cell tumors in F344 rats: Proposed mechanism. Med. Hypotheses 50, 525-529.
24. Oishi, K., Yoshida, O., and Schroeder, F. H. ( 1995). The geography of prostate cancer and its treatment in Japan. Cancer Surv. 23, 267-280.
25. Price, D. (1963). Comparative aspects of development and structure in the prostate. Monogr. Natl. Cancer Inst. 12, 1-25.
26. Roberts, S. A., Nett, T. M., Hartman, H. A., Adams, T. E., and Stoll, R. E. (1989). SDZ 200-110 induces Leydig cell tumors by increasing gonadotropins in rats. J. Am. Coll Toxicol. 8, 487-505.
27. Shirai, T., Iwasaki, S., Masui, T., Mori, T., Kato, T., and Ito, N. (1993). Enhancing effect of cadmium on rat ventral prostate carcinogenesis induced by 3,2′-dimethyl-4-aminobiphenyl. Jpn. J. Cancer Res. 84, 1023-1030.
28. Shiraishi, N., and Waalkes, M. P. (1996) Acquired tolerance to cadmium-induced toxicity in the rodent testes. Toxic Subst. Mech. 15, 27-42.
29. Slayter, M. V., Anzano, M. A., Kadomatsu, K., Smith, J. M., and Sporn, M. B. (1994). Histogenesis of induced prostate and seminal vesicle carcinoma in Lobund-Wistar rats: A system for histological scoring and grading. Cancer Res. 54, 1440-1445.
30. Waalkes, M. P. (1995). Cadmium and carcinogenesis. In Handbook on Metal-Ligand Interactions of Biological Fluids (Berthan, G., Ed.), Vol. 2, pp. 471-482. Marcel Dekker; New York.
31. Waalkes, M. P., and Goering, P. L. (1990). Metallothionein and other cadmium-binding proteins: Recent developments. Chem. Res. Toxicol. 3, 281-288.
32. Waalkes, M. P., Kovatch, R., and Rehm, S. (1991). Effect of chronic dietary zinc deficiency on cadmium toxicity and carcinogenesis in the male Wistar [Hsd:(WI)BR] rat. Toxicol. Appl. Pharmacol. 108, 448-456.
33. Waalkes, M. P., and Misra, R. R. (1996). Cadmium carcinogenicity and genotoxicity. In Toxicology of Metals (L. W. Chang, Ed.), pp. 231-244. CRC Press, Boca Raton.
34. Waalkes, M. P. and Rehm, S. (1992). Carcinogenicity of oral cadmium in the male Wistar (WF/NCr) rat: Effect of chronic dietary zinc deficiency. Fund. Appl. Toxicol. 19, 512-520.
35. Waalkes, M. P. and Rehm, S. (1994). Cadmium and prostate cancer. J. Toxicol. Environ. Health 43, 251-269.
36. Waalkes, M. P., Rehm, S., Coogan, T. P., and Ward, J. M. (1997a). Role of cadmium in the etiology of cancer of the prostate. In Target Organ Toxicology Series: Endocrine Toxicology (J. A. Thomas and H. D. Colby. Eds.), pp. 227-244. Raven Press, New York.
37. Waalkes, M. P., Rehm, S., and Devor, D. E. (1997b). The effects of continuous testosterone exposure on spontaneous and cadmium-induced tumors in the male Fischer (F344/NCr) rat: Loss of testicular response. Toxicol Appl. Pharmacol 142, 40-46.
38. Waalkes, M. P., Rehm, S., Riggs, C. W., Bare, R. M., Devor, D. E., Poirier, L. A., Wenk, M. L., and Henneman, J. R. (1989). Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: Dose-response analysis of effects of zinc on tumor induction in the prostate, in the testes, and at the injection site. Cancer Res. 49, 4282-4288.
39. Waalkes, M. P., Rehm. S., Riggs, C. W., Bare, R. M., Devor, D. E., Poirier, L. A., Wenk, M. L., Henneman, J. R., and Balaschak, M. S. (1988). Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: Dose-response analysis of tumor induction in the prostate and testes and at the injection site. Cancer Res. 48, 4656-4663.
40. West, D. W., Slattery, M. L., Robison, L. M., French, T. K., and Mahoney, A. W. (1991). Adult dietary intake and prostate cancer risk in Utah: A case-control study with special emphasis on aggressive tumors. Cancer Causes Control 2, 85-94.
41. Yamada, T., Nakamura, J., Murakami, M., Okuno, Y., Hosokawa, S., Matsuo, M., and Yamada H. (1994). The correlation of serum luteinizing hormone levels with the induction of Leydig cell tumors in rats by oxolinic acid. Toxicol. Appl. Pharmacol. 129, 146-154.
42. Yan, H., Carter, C. E., Xu, C., Singh, P. K., Jones, M. M., Johnson, J. E., and Dietrich, M. S. (1997). Cadmium-induced apoptosis in the urogenital organs of the male rat and its suppression by chelation. J. Toxicol. Environ. Health 10, 149-168.